204 related articles for article (PubMed ID: 17365217)
1. Special issue on active controlled clinical trials: guest editor's note.
Tsong Y
J Biopharm Stat; 2007; 17(2):197-9. PubMed ID: 17365217
[No Abstract] [Full Text] [Related]
2. Group sequential test strategies for superiority and non-inferiority hypotheses in active controlled clinical trials.
Wang SJ; Hung HM; Tsong Y; Cui L
Stat Med; 2001 Jul; 20(13):1903-12. PubMed ID: 11427948
[TBL] [Abstract][Full Text] [Related]
3. Special issue of statistical genetics and genomics in clinical trials: guest editor's note.
Wu R; Lin M
J Biopharm Stat; 2010 Mar; 20(2):191-2. PubMed ID: 20309753
[No Abstract] [Full Text] [Related]
4. Simultaneous test for superiority and noninferiority hypotheses in active-controlled clinical trials.
Tsong Y; Zhang J
J Biopharm Stat; 2007; 17(2):247-57. PubMed ID: 17365221
[TBL] [Abstract][Full Text] [Related]
5. The number needed to be treated as a valuable parameter in interpreting clinical trial findings.
Bannwarth B
Rev Rhum Engl Ed; 1999 Jun; 66(6):361-2. PubMed ID: 10418070
[No Abstract] [Full Text] [Related]
6. Editor's response to "ethical issues associated with globalization of placebo-controlled trials in pulmonary arterial hypertension".
Park MH; Rubin LJ
J Heart Lung Transplant; 2010 Jul; 29(7):827-8. PubMed ID: 20417131
[No Abstract] [Full Text] [Related]
7. Bio-creep in non-inferiority clinical trials.
Everson-Stewart S; Emerson SS
Stat Med; 2010 Nov; 29(27):2769-80. PubMed ID: 20809482
[TBL] [Abstract][Full Text] [Related]
8. Choice of delta noninferiority margin and dependency of the noninferiority trials.
Tsong Y; Zhang J; Levenson M
J Biopharm Stat; 2007; 17(2):279-88. PubMed ID: 17365224
[TBL] [Abstract][Full Text] [Related]
9. Simultaneous testing of noninferiority and superiority increases the false discovery rate.
Ng TH
J Biopharm Stat; 2007; 17(2):259-64. PubMed ID: 17365222
[TBL] [Abstract][Full Text] [Related]
10. On tests of the overall treatment effect in meta-analysis with normally distributed responses.
Hartung J; Knapp G
Stat Med; 2001 Jun; 20(12):1771-82. PubMed ID: 11406840
[TBL] [Abstract][Full Text] [Related]
11. Test for the consistency of noninferiority from multiple clinical trials.
Yan X; Wang MC; Su X
J Biopharm Stat; 2007; 17(2):265-78. PubMed ID: 17365223
[TBL] [Abstract][Full Text] [Related]
12. The advancement of controlled clinical trials.
Bren L
FDA Consum; 2007; 41(2):23-30. PubMed ID: 17582863
[No Abstract] [Full Text] [Related]
13. Clinical trials of antidepressants: "enrichment strategies".
Miller LE
Clin Pharmacol Ther; 2011 Apr; 89(4):485; author reply 486-7. PubMed ID: 21326291
[No Abstract] [Full Text] [Related]
14. Mixed noninferiority margin and statistical tests in active controlled trials.
Tsou HH; Hsiao CF; Chow SC; Yue L; Xu Y; Lee S
J Biopharm Stat; 2007; 17(2):339-57. PubMed ID: 17365228
[TBL] [Abstract][Full Text] [Related]
15. The ethics of placebo-controlled trials--a middle ground.
Emanuel EJ; Miller FG
N Engl J Med; 2001 Sep; 345(12):915-9. PubMed ID: 11565527
[No Abstract] [Full Text] [Related]
16. Ethics of placebo-controlled clinical trials in multiple sclerosis: a reassessment.
Tenser RB; Polman CH
Neurology; 2009 Mar; 72(13):1191-2; author reply 1192. PubMed ID: 19332703
[No Abstract] [Full Text] [Related]
17. Assessment of blinding in clinical trials.
Bang H; Ni L; Davis CE
Control Clin Trials; 2004 Apr; 25(2):143-56. PubMed ID: 15020033
[TBL] [Abstract][Full Text] [Related]
18. Guest editor's note: missing data--moving forward.
Soon GG
J Biopharm Stat; 2011 Mar; 21(2):177-9. PubMed ID: 21390994
[No Abstract] [Full Text] [Related]
19. New tests for null hypothesis of non unity ratio of proportions.
Koti KM
J Biopharm Stat; 2007; 17(2):229-45. PubMed ID: 17365220
[TBL] [Abstract][Full Text] [Related]
20. Clinician-trialist rounds: 5. Cointervention bias--how to diagnose it in their trial and prevent it in yours.
Sackett DL
Clin Trials; 2011 Aug; 8(4):440-2. PubMed ID: 21835863
[No Abstract] [Full Text] [Related]
[Next] [New Search]
